Announcement of transactions with shares and linked securities in H. Lundbeck A/S made by executives

Announcement of transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated persons and legal entities

ID: 51969

(Thomson Reuters ONE) -




H. Lundbeck A/S hereby reports transactions made by executives and persons and
legal entities closely associated to them with shares in H. Lundbeck A/S and
linked securities, cf. section 28a of the Danish Securities Trading Act.

The list is based on reports received by H. Lundbeck A/S from the company's
executives today or yesterday.


+-----------------------------------------+---------------------+
|Name: |Egil Bodd |
|  | |
+-----------------------------------------+---------------------+
|Job position of the executive: |Board member |
|  | |
+-----------------------------------------+---------------------+
|Relation to executive |  |
|(associated person or legal entity): | |
+-----------------------------------------+---------------------+
|ID code (ISIN code): |DK 0010287234 |
|  | |
+-----------------------------------------+---------------------+
|Description of the security: |Share |
|  | |
+-----------------------------------------+---------------------+
|Nature of the transaction: |Sale of shares |
|  | |
+-----------------------------------------+---------------------+
|Date of trading: |28 February 2011 |
|  | |
+-----------------------------------------+---------------------+
|Market on which the trading was effected:|Nasdaq OMX Copenhagen|




| |  |
+-----------------------------------------+---------------------+
|Number of traded securities: | 8,000 Shares |
|  | |
+-----------------------------------------+---------------------+
|Market price of securities traded: |971,701 DKK |
|  | |
+-----------------------------------------+---------------------+

Persons/entities under an obligation to report
Persons or entities under an obligation to report are defined as members of the
Executive Management and the Supervisory Board of H. Lundbeck A/S and
persons/entities closely associated to them.

Closely associated persons/entities means inter alia:

* spouse or cohabitant

* children below the age of 18

* legal entities in which the insider has a controlling influence

The content of this release will have no influence on the Lundbeck Group's
financial expectations for 2011.


Lundbeck contacts


Investors: Media:



Palle Holm Olesen Mads Kronborg

Chief Specialist, Investor Relations Media Relations Manager

+45 36 43 24 26 +45 36 43 28 51



Magnus Thorstholm Jensen Stine Hove Marsling

Investor Relations Officer External Communication Specialist

+45 36 43 38 16 +45 36 43 28 33



Jacob Tolstrup

Vice President

+1 847 282 5713



About Lundbeck
H. Lundbeck A/S (LUN.CO, LUN DC, HLUKY) is an international pharmaceutical
company highly committed to improving the quality of life for people suffering
from central nervous system (CNS) disorders. For this purpose, Lundbeck is
engaged in the research, development, production, marketing and sale of
pharmaceuticals across the world. The company's products are targeted at
disorders such as depression and anxiety, schizophrenia, insomnia, epilepsy and
Huntington's, Alzheimer's and Parkinson's diseases.

Lundbeck was founded in 1915 by Hans Lundbeck in Copenhagen, Denmark. Today
Lundbeck employs approximately 5,900 people worldwide. Lundbeck is one of the
world's leading pharmaceutical companies working with CNS disorders. In 2010,
the company's revenue was DKK 14.8 billion (approximately EUR 2.0 billion or USD
2.6 billion). For more information, please visit www.lundbeck.com.



Release no 427:
http://hugin.info/130085/R/1492978/428727.pdf




This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.

Source: H. Lundbeck A/S via Thomson Reuters ONE

[HUG#1492978]


Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  CellaVisions new product concept for hospital networks enters the evaluation phase Confirmed Net Asset Value(s)
Bereitgestellt von Benutzer: hugin
Datum: 28.02.2011 - 15:08 Uhr
Sprache: Deutsch
News-ID 51969
Anzahl Zeichen: 5578

contact information:
Town:

Valby



Kategorie:

Business News



Diese Pressemitteilung wurde bisher 169 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Announcement of transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated persons and legal entities"
steht unter der journalistisch-redaktionellen Verantwortung von

H. Lundbeck A/S (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von H. Lundbeck A/S



 

Werbung



Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z